Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

H. Segal, Brahm; Herbrecht, Raoul; A. Stevens, David; Ostrosky‐Zeichner, Luis; D. Sobel, Jack; Viscoli, Claudio; J. Walsh, Thomas; Maertens, Johan; F. Patterson, Thomas; R. Perfect, John; Dupont, B.; R. Wingard, John; Calandra, Thierry; A. Kauffman, Carol; R. Graybill, John; R. Baden, Lindsey; G. Pappas, Peter; E. Bennett, John; P. Kontoyiannis, Dimitrios; Cordonnier, Catherine; A. Viviani, M.; Billé, Jacques; G. Almyroudis, Nikolaos; Joseph Wheat, L.; Graninger, Wolfgang; J. Bow, Eric; M. Holland, Steven; Jan Kullberg, Bart; E. Dismukes, William; de Pauw, B.E.

doi:10.1086/590566

Public

Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

Published in Clinical Infectious Diseases • Jul 18, 2008

Authors:

Brahm H. Segal

Raoul Herbrecht

David A. Stevens

Abstract

Invasive fungal diseases (IFDs) have become major causes of morbidity and mortality among highly immunocompromised patients. Authoritative consensus criteria to diagnose IFD have been useful in establishing eligibility criteria for antifungal trials. There is an important need for generation of cons...

Subject

Medicine

Clinical trial

Coccidioides

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!